Takeda Pharmaceutical Co Ltd (NYSE:TAK)

20.59
Delayed Data
As of Nov 20
 -0.24 / -1.15%
Today’s Change
15.50
Today|||52-Week Range
21.61
+22.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues3.9B4.4B6.5B7.7B
 
 
 
 
 
Cost of Goods Sold857.6M1.2B2.3B2.7B
 
 
 
 
 
Depreciation And Amortization353.6M339.9M1.4B--
 
 
 
 
 
Operating ExpensesGross Income2.7B2.9B2.8B5.0B
 
 
 
 
 
General Expenses2.1B2.1B3.5B3.2B
 
 
 
 
 
Other Operating Expenses0.000.000.001.3B
 
 
Research And Development712.9M686.9M1.3B1.1B
 
 
 
 
 
Total Operating Expenses3.3B3.6B7.3B7.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income571.5M872.8M-746.1M402.0M
 
 
 
 
 
Extraordinary Charge-38.4M-98.0M-740.5M--
 
 
 
 
Pre-Tax Equity Earnings4.2M-425.6M3.0M21.3M
 
 
 
 
 
Interest Expense On Debt81.7M197.5M379.2M419.1M
 
 
 
 
 
Other Expenses122.6M222.4M765.3M-312.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income600.3M422.1M-1.0B-229.1M
 
 
 
 
 
Income Taxes-166.0M-86.3M-527.9M-41.4M
 
 
 
 
 
Minority Interest-152.5K-869.0K-281.4K-218.3K
 
 
 
 
 
Net Income434.4M334.9M-502.1M-188.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.6B1.6B3.1B3.1B
 
 
 
 
 
Shares To Calculate EPS Diluted1.6B1.6B3.1B3.1B
 
 
 
 
 
 
Earnings Per ShareEPS$0.28$0.21-$0.16-$0.06
 
 
 
 
 
EPS Diluted$0.28$0.21-$0.16-$0.06